Our services

Advance your compounds to the clinic with confidence

We are seasoned specialists in chronic pain and neurodegenerative disease drug discovery with a deep understanding for Client needs. We have a proven track record of developing customer specific solutions for our Clients to ensure project progress.
Read more arrow_forward

We deliver high quality information

We’re not just providing data, we provide valuable information and clear answers to complex biological questions.

We accelerate your decision-making

Thanks to our highly experienced team, proprietary discovery platform and streamlined operations, we can shorten your project lead times.

Fast access to ground-breaking assays

We develop highly innovative in vitro assays based on complex biology that provide translationally relevant information.


An approach you can trust

We provide fully collaborative support, tailored to each individual study. Our Clients value our interactive and open communication style, our high capacity, quality and delivery precision needed for projects from target discovery and screening to lead optimization.

Read more

Our platform

Our unique discovery platform

Our team of highly experienced neurobiologists, stem cell researchers and engineers, has developed a unique and patent protected discovery platform which enables development of innovative in vitro assays of enhanced translational value.
Read more arrow_forward

News and events

Latest news and insights

Cellectricon values scientific exchange and we invite you to take part of our latest news, newsletters and to learn about upcoming events.

Read more

Join our team! Cellectricon is looking for an experienced laboratory assistant to support our ongoing customer projects
Cellectricon is an innovative discovery services provider in the areas of chronic pain and CNS in vitro research. We are...
March 26-31, 2019
AD/PD 2019
AD/PD™ 2019, the 14th​ International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders takes place in Lisbon, Portugal on...
December 6, 2018. 11 am EST
Webinar - Development of a novel assay platform for functional neuronal in vitro modelling of Tau pathology
Webinar Description: The progressive deposition of misfolded Tau protein is a pathological hallmark of several neurodegenerative diseases, collectively called tauopathies,...
Cellectricon announces new opportunity for the discovery of highly differentiated therapeutics for neurodegenerative diseases
Launch of novel, high throughput in vitro platform will help researchers find molecules that can prevent prion-like spreading of neurodegenerative...
November 3-7, 2018
Neuroscience 2018
Cellectricon would like to thank for all the rewarding scientific interactions at the recent Neuroscience 2018 meeting.  Especially, we appreciate...
Henrik Zetterberg joins Cellectricon's advisory board
Cellectricon, a collaborative services provider dedicated to advance drug discovery and research in the areas of chronic pain and CNS...
Cellectricon strengthens Scientific Advisory Board
To further enhance Cellectricon’s expertise in Chronic Pain drug discovery, the company is today announcing the addition of another highly...

Get the latest news & events – sign up for our newsletter

Read about our Privacy Policy